About Bioheaven 360
Bioheaven 360 is a company based in Delhi (India) founded in 2018. Bioheaven 360 has raised $264.39 thousand across 3 funding rounds from investors including Digital Futurists Angels, Christudas Philipose Anchuturuthen and Hiren Thakkar. Bioheaven 360 offers products and services including Biologicals, Biosimilars, AI-based Intel Generation, and Cell Therapies. Bioheaven 360 operates in a competitive market with competitors including Natera, ArcherDX, Variantyx, ImaginAb and Lantern Pharma, among others.
- Headquarter Delhi, India
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioheaven 360 Genotec Private Limited
- Date of Incorporation 27 Mar, 2018
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$124.87 K (USD)157.27as on Mar 31, 2023
-
Net Profit
$915.35 (USD)-14.68as on Mar 31, 2023
-
EBITDA
$13.23 K (USD)418.14as on Mar 31, 2023
-
Total Equity Funding
$264.39 K (USD)
in 3 rounds
-
Latest Funding Round
$122.9 K (USD), Seed
Jan 16, 2023
-
Investors
Digital Futurists Angels
& 37 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioheaven 360
Bioheaven 360 offers a comprehensive portfolio of products and services, including Biologicals, Biosimilars, AI-based Intel Generation, and Cell Therapies.
Products for immunology, cell therapies, and biosimilars development.
Alternatives to biological medicines for disease treatment.
AI solutions for industry-specific biological data integration.
Treatments using stem cells for regeneration and health improvement.
Funding Insights of Bioheaven 360
Bioheaven 360 has successfully raised a total of $264.39K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $122.9 thousand completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bioheaven 360
Bioheaven 360 has secured backing from 38 investors, including venture fund and angel investors. Prominent investors backing the company include Digital Futurists Angels, Christudas Philipose Anchuturuthen and Hiren Thakkar.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of technology consulting and focused on multiple sectors
|
Locked | Locked | Locked | |
|
CP
Christudas Philipose Anchuturuthen |
-
|
Locked | Locked | Locked |
|
HT
Hiren Thakkar |
Angel investor and entrepreneur, focused on tech startups in India.
|
Locked | Locked | Locked |
Investor details for Bioheaven 360
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioheaven 360
Investment portfolio details for Bioheaven 360
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bioheaven 360
Detailed financials for Bioheaven 360
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioheaven 360 Comparisons
Peer comparison for Bioheaven 360
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioheaven 360
Bioheaven 360 operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, ArcherDX, Variantyx, ImaginAb and Lantern Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Genomics data analysis platform for healthcare diagnostics is offered.
|
|
| Locked | Locked | Locked |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| Locked | Locked | Locked |
Drug and companion diagnostics for multi-drug resistant cancers are developed.
|
|
| Locked | Locked | Locked |
Developer of technologies for the analysis of rare and single cells in the blood
|
Detailed competitors of Bioheaven 360
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioheaven 360
Complete news archive for Bioheaven 360
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioheaven 360
Bioheaven 360 was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Bioheaven 360 is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Bioheaven 360 is a funded company, having raised a total of $264.39K across 3 funding rounds to date.
Annual revenue of Bioheaven 360 is $124.87K as on Mar 31, 2023.
Bioheaven 360 was established in 2018 in Delhi, India, within the biotechnology sector. AI and machine learning models for patient classification are utilized in clinical environments to enable early detection of osteoporosis. Genomics-based diagnostics tools are offered for disease risk prediction, supporting healthcare applications focused on preventive classification and assessment.
Bioheaven 360's top competitors include Natera, ImaginAb and Lantern Pharma.
Bioheaven 360 offers Biologicals, Biosimilars, AI-based Intel Generation, and Cell Therapies.
Bioheaven 360 has 38 investors. Key investors include Digital Futurists Angels, Christudas Philipose Anchuturuthen, Hiren Thakkar, Sachin Seth, and Jigar Shah.
The valuation of Bioheaven 360 is $1.44M as of Jun 2022.